Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2014

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The Company incurred losses for the years ended December 31, 2014, 2013 and 2012. For all periods presented, all equity instruments are excluded from the calculation of diluted earnings (loss) per share as the effect of such shares is anti-dilutive. The weighted average number of equity instruments excluded consist of:



	Year Ended December 31,
	2014	2013	2012
Stock Options	2,179,643	2,725,632	2,865,861
Stock-Settled Stock Appreciation Rights	388,325	439,056	421,020
Restricted Stock Units	1,206,534	981,645	351,011
Warrants	772,903	1,802,820	2,263,538

Fair Value Measurements, Recurring and Nonrecurring

At December 31, 2014 and 2013, the fair value of such liability classified warrants was as follows:



	2014		2013
Common stock warrants, current	$	—	$	313,425
Common stock warrants, non-current	—		—
	$	—	$	313,425

- Definition

Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.

+ References+ Details